ReP USP - Resultado da busca

Artigo de periodico
Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy (2021)
Mori, Augusto Akira ; Castro, Lara Reinel de; Bortolin, Raul Hernandes ; Bastos, Gisele Medeiros; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Hirata, Thiago Dominguez Crespo ; Fajardo, Cristina Moreno ; Sampaio, Marcelo Ferraz; Moreira, Dalmo Antonio Ribeiro ; Mateos, José Carlos Pachon; Correia, Edileide de Barros; Sousa, Amanda Guerra de Moraes Rego ; Brion, Maria ; Carracedo, Angel ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Forensic Science International. Unidades: FCF, IDPC
Subjects: MORTE SÚBITA, HIPERTROFIA VENTRICULAR ESQUERDA, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORI, Augusto Akira et al. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy. Forensic Science International, v. 52, p. 1-10 art. 102478, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.fsigen.2021.102478. Acesso em: 16 nov. 2024.
APA
Mori, A. A., Castro, L. R. de, Bortolin, R. H., Bastos, G. M., Oliveira, V. F. de, Ferreira, G. M., et al. (2021). Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy. Forensic Science International, 52, 1-10 art. 102478. doi:10.1016/j.fsigen.2021.102478
NLM
Mori AA, Castro LR de, Bortolin RH, Bastos GM, Oliveira VF de, Ferreira GM, Hirata TDC, Fajardo CM, Sampaio MF, Moreira DAR, Mateos JCP, Correia E de B, Sousa AG de MR, Brion M, Carracedo A, Hirata RDC, Hirata MH. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy [Internet]. Forensic Science International. 2021 ; 52 1-10 art. 102478.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.fsigen.2021.102478
Vancouver
Mori AA, Castro LR de, Bortolin RH, Bastos GM, Oliveira VF de, Ferreira GM, Hirata TDC, Fajardo CM, Sampaio MF, Moreira DAR, Mateos JCP, Correia E de B, Sousa AG de MR, Brion M, Carracedo A, Hirata RDC, Hirata MH. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy [Internet]. Forensic Science International. 2021 ; 52 1-10 art. 102478.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.fsigen.2021.102478
Artigo de periodico
Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients (2021)
Cerda, Alvaro ; Amaral, Adonai Aralim; Oliveira, Raquel de; Moraes, Tamiris Invencioni; Braga, Aécio Assunção; Saldarriaga, Magda Elizabeth Graciano; Fajardo, Cristina Moreno ; Hirata, Thiago Dominguez Crespo ; Bonezi, Vivian; Salazar, Antony Brayan Campos ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: International of Journal Molecular Sciences. Unidades: FCF, HU
Subjects: OBESIDADE, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients. International of Journal Molecular Sciences, v. 22, p. 1-14 art. 1468, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22031468. Acesso em: 16 nov. 2024.
APA
Cerda, A., Amaral, A. A., Oliveira, R. de, Moraes, T. I., Braga, A. A., Saldarriaga, M. E. G., et al. (2021). Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients. International of Journal Molecular Sciences, 22, 1-14 art. 1468. doi:10.3390/ijms22031468
NLM
Cerda A, Amaral AA, Oliveira R de, Moraes TI, Braga AA, Saldarriaga MEG, Fajardo CM, Hirata TDC, Bonezi V, Salazar ABC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients [Internet]. International of Journal Molecular Sciences. 2021 ; 22 1-14 art. 1468.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ijms22031468
Vancouver
Cerda A, Amaral AA, Oliveira R de, Moraes TI, Braga AA, Saldarriaga MEG, Fajardo CM, Hirata TDC, Bonezi V, Salazar ABC, Dórea EL, Bernik MMS, Hirata MH, Hirata RDC. Peripheral blood mirome identified miR-155 as potential biomarker of MetS and cardiometabolic risk in obese patients [Internet]. International of Journal Molecular Sciences. 2021 ; 22 1-14 art. 1468.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ijms22031468
Artigo de periodico
Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients (2021)
Hirata, Thiago Dominguez Crespo ; Hernandez, Carolina Dagli ; Genvigir, Fabiana Dalla Vecchia ; Lauschke, Volker Martin ; Zhou, Yitian ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Molecular Diagnosis and Therapy. Unidade: FCF
Subjects: ANTICOAGULANTES, DOENÇAS CARDIOVASCULARES, TROMBOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Thiago Dominguez Crespo et al. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients. Molecular Diagnosis and Therapy, v. 25, p. 735–755, 2021Tradução . . Disponível em: https://doi.org/10.1007/s40291-021-00549-z. Acesso em: 16 nov. 2024.
APA
Hirata, T. D. C., Hernandez, C. D., Genvigir, F. D. V., Lauschke, V. M., Zhou, Y., Hirata, M. H., & Hirata, R. D. C. (2021). Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients. Molecular Diagnosis and Therapy, 25, 735–755. doi:10.1007/s40291-021-00549-z
NLM
Hirata TDC, Hernandez CD, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients [Internet]. Molecular Diagnosis and Therapy. 2021 ; 25 735–755.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s40291-021-00549-z
Vancouver
Hirata TDC, Hernandez CD, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients [Internet]. Molecular Diagnosis and Therapy. 2021 ; 25 735–755.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s40291-021-00549-z
Artigo de periodico
Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells (2021)
Cerda, Alvaro ; Bortolin, Raul Hernandes ; Manriquez, Victor; Salazar, Luis A ; Zambrano, Tomás ; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacological Reports. Unidade: FCF
Subjects: MICRORNAS, LIPÍDEOS, MICRORNAS, EXPRESSÃO GÊNICA, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, v. 73, p. 1-13 art. 868–880, 2021Tradução . . Disponível em: https://doi.org/10.1007/s43440-021-00241-3. Acesso em: 16 nov. 2024.
APA
Cerda, A., Bortolin, R. H., Manriquez, V., Salazar, L. A., Zambrano, T., Fajardo, C. M., et al. (2021). Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells. Pharmacological Reports, 73, 1-13 art. 868–880. doi:10.1007/s43440-021-00241-3
NLM
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Vancouver
Cerda A, Bortolin RH, Manriquez V, Salazar LA, Zambrano T, Fajardo CM, Hirata MH, Hirata RDC. Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells [Internet]. Pharmacological Reports. 2021 ; 73 1-13 art. 868–880.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s43440-021-00241-3
Artigo de periodico
Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Caroline Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M ; Faludi, André Arpad ; Rodrigues, Alice Cristina ; Bastos, Gisele Medeiros ; Jannes, Cinthia Elim ; Pereira , Alexandre C ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidades: IDPC, ICB, FCF
Subjects: HIPERCOLESTEROLEMIA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 16 nov. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases (2021)
Freitas, Renata Caroline Costa de ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Aikawa, Elena
Source: Biomolecules. Unidade: FCF
Subjects: BIOMARCADORES, PROTEÍNAS, LIPÍDEOS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases. Biomolecules, v. 11, p. 1-21 art. 388, 2021Tradução . . Disponível em: https://doi.org/10.3390/biom11030388. Acesso em: 16 nov. 2024.
APA
Freitas, R. C. C. de, Hirata, R. D. C., Hirata, M. H., & Aikawa, E. (2021). Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases. Biomolecules, 11, 1-21 art. 388. doi:10.3390/biom11030388
NLM
Freitas RCC de, Hirata RDC, Hirata MH, Aikawa E. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases [Internet]. Biomolecules. 2021 ; 11 1-21 art. 388.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/biom11030388
Vancouver
Freitas RCC de, Hirata RDC, Hirata MH, Aikawa E. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases [Internet]. Biomolecules. 2021 ; 11 1-21 art. 388.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/biom11030388
Trabalho de evento
Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina (2021)
Rodrigues, Vitor Pitta; Araujo, Neire Niara Ferreira de; Bastos, Gisele Medeiros ; Hernandez, Carolina Dagli ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Posters. Conference titles: Reunião Anual da SBPC (Virtual). Unidade: FCF
Subjects: ANTICOAGULANTES, POLIMORFISMO, GENÉTICA, FARMACOGENÉTICA, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Vitor Pitta et al. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina. 2021, Anais.. São Paulo: SBPC, 2021. Disponível em: https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf. Acesso em: 16 nov. 2024.
APA
Rodrigues, V. P., Araujo, N. N. F. de, Bastos, G. M., Hernandez, C. D., Hirata, R. D. C., & Hirata, M. H. (2021). Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina. In Posters. São Paulo: SBPC. Recuperado de https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf
NLM
Rodrigues VP, Araujo NNF de, Bastos GM, Hernandez CD, Hirata RDC, Hirata MH. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina [Internet]. Posters. 2021 ;[citado 2024 nov. 16 ] Available from: https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf
Vancouver
Rodrigues VP, Araujo NNF de, Bastos GM, Hernandez CD, Hirata RDC, Hirata MH. Proposta de medicina personalizada utilizando perfil farmacogenético em pacientes idosos usuários de varfarina [Internet]. Posters. 2021 ;[citado 2024 nov. 16 ] Available from: https://reunioes.sbpcnet.org.br/73RA/inscritos/resumos/10242_1f340f1b1f65b6df5b5e3f94d95b11daf.pdf
Artigo de periodico
Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Carolina Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M. ; Faludi, André A. ; Bastos, Gisele M. ; Jannes, Cinthia E. ; Pereira, Alexandre C. ; Rodrigues, Alice Cristina ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidades: ICB, FCF
Subjects: FARMACOLOGIA, HIPERCOLESTEROLEMIA, VARIAÇÃO GENÉTICA, MICRORNAS, ENVELHECIMENTO, RNA MENSAGEIRO, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 16 nov. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report (2021)
Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Marçal, Elisangela da Silva Rodrigues; Gonçalves, Rodrigo Marques; Faludi, André Arpad; Borges, Jéssica Bassani ; Bastos, Gisele Medeiros ; Los, Bruna; Mori, Augusto Akira ; Bortolin, Raul Hernandes ; Ferreira, Glaucio Monteiro ; Oliveira, Victor Fernandes de ; Hirata, Thiago Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Annals of Translational Medicine. Unidades: IDPC, FCF
Subjects: HIPERCOLESTEROLEMIA, ESTATINAS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report. Annals of Translational Medicine, v. 9, n. 1, p. 1-8 art. 76, 2021Tradução . . Disponível em: https://doi.org/10.21037/atm-20-5540. Acesso em: 16 nov. 2024.
APA
Hernandez, C. D., Freitas, R. C. C. de, Marçal, E. da S. R., Gonçalves, R. M., Faludi, A. A., Borges, J. B., et al. (2021). Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report. Annals of Translational Medicine, 9( 1), 1-8 art. 76. doi:10.21037/atm-20-5540
NLM
Hernandez CD, Freitas RCC de, Marçal E da SR, Gonçalves RM, Faludi AA, Borges JB, Bastos GM, Los B, Mori AA, Bortolin RH, Ferreira GM, Oliveira VF de, Hirata TDC, Hirata MH, Hirata RDC. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report [Internet]. Annals of Translational Medicine. 2021 ; 9( 1): 1-8 art. 76.[citado 2024 nov. 16 ] Available from: https://doi.org/10.21037/atm-20-5540
Vancouver
Hernandez CD, Freitas RCC de, Marçal E da SR, Gonçalves RM, Faludi AA, Borges JB, Bastos GM, Los B, Mori AA, Bortolin RH, Ferreira GM, Oliveira VF de, Hirata TDC, Hirata MH, Hirata RDC. Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with familial hypercholesterolemia: a case report [Internet]. Annals of Translational Medicine. 2021 ; 9( 1): 1-8 art. 76.[citado 2024 nov. 16 ] Available from: https://doi.org/10.21037/atm-20-5540
Artigo de periodico
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol (2021)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Los, Bruna; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Gonçalves, Rodrigo Marques; Araújo, Daniel Branco de; Zatz, Henry Paulo; Bertolami, Adriana; Faludi, André Arpad; Bertolami, Marcelo Chiara ; Sousa, Amanda Guerra de Moraes Rego ; França, Joao Italo Dias ; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Nakazone, Marcelo Arruda; Souza, Dorotéia Rossi Silva; Carmo, Tayanne Silva; Sampaio, Marcelo Ferraz; Gorjão, Renata ; Curi, Tania Cristina Pithon ; Moriel, Patricia; Silbiger, Vivian Nogueira ; Luchessi, André Ducati ; Araújo, Jéssica Nayara Góes de; Naslavsky, Michel ; Wang, Jaqueline Yu Ting; Kronenberger, Thales ; Cerda, Alvaro ; Wang, Hui Tzu Lin; Garofalo, Adriana Regina; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Research in Social and Administrative Pharmacy. Unidades: FCF, IDPC, FM, IB
Subjects: GENÔMICA, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, EXONS, LINFÓCITOS, LINHAGEM CELULAR, MUTAGÊNESE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, v. 17, n. 7, p. 1347-1355, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2020.10.007. Acesso em: 16 nov. 2024.
APA
Borges, J. B., Oliveira, V. F. de, Ferreira, G. M., Los, B., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2021). Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, 17( 7), 1347-1355. doi:10.1016/j.sapharm.2020.10.007
NLM
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Vancouver
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Artigo de periodico
High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome (2021)
Braga, Aécio Assunção ; Bortolin, Raul Hernandes ; Saldarriaga, Magda Elizabeth Graciano ; Hirata, Thiago Dominguez Crespo ; Cerda, Alvaro; Freitas, Renata Caroline Costa de ; Wang, Hui Tzu Lin ; Borges, Jessica B; França, Joao Italo Dias ; Masi, Laureane Nunes ; Curi, Rui ; Curi, Tania Cristina Phiton ; Sampaio, Marcelo Ferraz; Castro, Lara R; Bastos, Gisele Medeiros ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidade: FCF
Subjects: ADIPOSIDADE, SÍNDROME X METABÓLICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Aécio Assunção et al. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, v. 13, n. 6 p. 423–436, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0247. Acesso em: 16 nov. 2024.
APA
Braga, A. A., Bortolin, R. H., Saldarriaga, M. E. G., Hirata, T. D. C., Cerda, A., Freitas, R. C. C. de, et al. (2021). High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, 13( 6 p. 423–436). doi:10.2217/epi-2020-0247
NLM
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/epi-2020-0247
Vancouver
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/epi-2020-0247
Trabalho de evento-resumo
Novos compostos com potencial atividade inibitória da PCSK9 evidenciados por modelagem molecular (2021)
Lopes, Vitor Galvão ; Ferreira, Glaucio Monteiro ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Resumos. Conference titles: Simpósio Internacional de Iniciação Científica e Tecnológica da USP/SIICUSP. Unidade: FCF
Assunto: MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Vitor Galvão et al. Novos compostos com potencial atividade inibitória da PCSK9 evidenciados por modelagem molecular. 2021, Anais.. São Paulo: Pró-Reitoria de Pesquisa/USP, 2021. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 16 nov. 2024.
APA
Lopes, V. G., Ferreira, G. M., Hirata, R. D. C., & Hirata, M. H. (2021). Novos compostos com potencial atividade inibitória da PCSK9 evidenciados por modelagem molecular. In Resumos. São Paulo: Pró-Reitoria de Pesquisa/USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
NLM
Lopes VG, Ferreira GM, Hirata RDC, Hirata MH. Novos compostos com potencial atividade inibitória da PCSK9 evidenciados por modelagem molecular [Internet]. Resumos. 2021 ;[citado 2024 nov. 16 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Vancouver
Lopes VG, Ferreira GM, Hirata RDC, Hirata MH. Novos compostos com potencial atividade inibitória da PCSK9 evidenciados por modelagem molecular [Internet]. Resumos. 2021 ;[citado 2024 nov. 16 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Trabalho de evento-resumo
Avaliação da atividade in vitro e características físicoquímicas de compostos potencialmente inibidores de 3CL-like protease de SARS-COV-2 (2021)
Barroso, Carolina Previdi Mesquita; Ferreira, Glaucio Monteiro ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Resumos. Conference titles: Simpósio Internacional de Iniciação Científica e Tecnológica da USP/SIICUSP. Unidade: FCF
Subjects: COVID-19, ANÁLISE TOXICOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROSO, Carolina Previdi Mesquita et al. Avaliação da atividade in vitro e características físicoquímicas de compostos potencialmente inibidores de 3CL-like protease de SARS-COV-2. 2021, Anais.. São Paulo: Pró-Reitoria de Pesquisa/USP, 2021. Disponível em: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210. Acesso em: 16 nov. 2024.
APA
Barroso, C. P. M., Ferreira, G. M., Hirata, M. H., & Hirata, R. D. C. (2021). Avaliação da atividade in vitro e características físicoquímicas de compostos potencialmente inibidores de 3CL-like protease de SARS-COV-2. In Resumos. São Paulo: Pró-Reitoria de Pesquisa/USP. Recuperado de https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
NLM
Barroso CPM, Ferreira GM, Hirata MH, Hirata RDC. Avaliação da atividade in vitro e características físicoquímicas de compostos potencialmente inibidores de 3CL-like protease de SARS-COV-2 [Internet]. Resumos. 2021 ;[citado 2024 nov. 16 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210
Vancouver
Barroso CPM, Ferreira GM, Hirata MH, Hirata RDC. Avaliação da atividade in vitro e características físicoquímicas de compostos potencialmente inibidores de 3CL-like protease de SARS-COV-2 [Internet]. Resumos. 2021 ;[citado 2024 nov. 16 ] Available from: https://uspdigital.usp.br/siicusp/siicPublicacao.jsp?codmnu=7210

USP Schools

ReP

Filtros

USP Schools

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration